Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 06, 2023

BUY
$285.76 - $321.48 $4,286 - $4,822
15 New
15 $4,000
Q4 2020

Feb 05, 2021

BUY
$207.01 - $276.09 $58,997 - $78,685
285 New
285 $68,000
Q3 2020

Oct 23, 2020

SELL
$255.65 - $303.1 $12,782 - $15,155
-50 Closed
0 $0
Q4 2019

Jan 22, 2020

BUY
$166.71 - $223.91 $8,335 - $11,195
50 New
50 $11,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Tompkins Financial Corp Portfolio

Follow Tompkins Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.